Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release
Authors:
Open Access
- 8 June 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (23) , e2301340
Abstract
The treatment of implant‐associated bacterial infections and biofilms is an urgent medical need and a grand challenge because biofilms protect bacteria from the immune system and harbor antibiotic‐tolerant persister cells. This need is addressed herein through an engineering of antibody‐drug conjugates (ADCs) that contain an anti‐neoplastic drug mitomycin C, which is also a potent antimicrobial against biofilms. The ADCs designed herein release the conjugated drug without cell entry, via a novel mechanism of drug release which likely involves an interaction of ADC with the thiols on the bacterial cell surface. ADCs targeted toward bacteria are superior by the afforded antimicrobial effects compared to the non‐specific counterpart, in suspension and within biofilms, in vitro, and in an implant‐associated murine osteomyelitis model in vivo. The results are important in developing ADC for a new area of application with a significant translational potential, and in addressing an urgent medical need of designing a treatment of bacterial biofilms.Keywords
Funding Information
- Danmarks Frie Forskningsfond (FTP‐ 9041‐00242A)
- Novo Nordisk Fonden (NNF19OC0058357)
This publication has 62 references indexed in Scilit:
- A Modified Chronic Infection Model for Testing Treatment of Staphylococcus aureus Biofilms on ImplantsPLOS ONE, 2014
- Prosthetic Joint InfectionClinical Microbiology Reviews, 2014
- Remote‐Controlled Hydrogel Depots for Time‐Scheduled VaccinationAdvanced Functional Materials, 2013
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trialThe Lancet Oncology, 2013
- Infection risk for primary and revision instrumented lumbar spine fusion in the Medicare populationJournal of Neurosurgery: Spine, 2012
- Inactivation of Staphylococcal Phenol Soluble Modulins by Serum Lipoprotein ParticlesPLOS Pathogens, 2012
- Synthetic Effects ofsecGandsecY2Mutations on Exoproteome Biogenesis inStaphylococcus aureusJournal of Bacteriology, 2010
- Contribution of exofacial thiol groups in the reducing activity of Lactococcus lactisThe FEBS Journal, 2010
- Polymicrobial Prosthetic Joint Infections: Risk Factors and OutcomeClinical Orthopaedics and Related Research, 2008
- Use of Liposomes to Deliver Bactericides to Bacterial Biofilms2005